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Introduction
The centrosome is the primary microtubule-organizing center of 
an animal cell that consists of two centrioles surrounded by peri-
centriolar material (PCM; Bettencourt-Dias and Glover, 2007). 
Centrosomes duplicate once per cell cycle, which involves the 
growing  of  procentrioles  (daughter  centrioles)  orthogonally 
to each of the two parental centrioles (Nigg, 2007; Strnad and 
Gönczy, 2008). In early mitosis, the two centrosomes separate 
and participate in mitotic spindle pole formation (Hinchcliffe 
and Sluder, 2001). Interestingly, there is a correlation between 
excess centrosomes, aneuploidy, and cancer (Nigg, 2006; Ganem 
et al., 2009). Extra centrosomes generate chromosomal instabil-
ity by exacerbating erroneous attachments of chromosomes to   
spindle microtubules (Ganem et al., 2009), which may contribute   
to cancer progression. Thus, understanding the regulatory mecha-
nisms governing centrosome duplication may provide insights 
into both normal cell behavior and tumorigenesis.
Centriole  formation  is  triggered  by  a  conserved  kinase, 
Plk4  (SAK;  Bettencourt-Dias  et  al.,  2005;  Habedanck  et  al., 
2005). Activation of Plk4 in human cells induces a cascade, includ-
ing hsSas6 (Leidel et al., 2005), CPAP (Kohlmaier et al., 2009; 
Tang et al., 2009), Cep135 (Ohta et al., 2002), -tubulin, and 
CP110 (Kleylein-Sohn et al., 2007) that are required at different 
stages of procentriole formation. Plk4 also induces de novo   
centriole formation and amplification of centrioles, leading to   
tumorigenesis in flies (Peel et al., 2007; Basto et al., 2008). Plk4
+/ 
mice develop spontaneous liver and lung tumors, suggesting that 
reduced Plk4 gene dosage increases the probability of mitotic   
errors and cancer development (Ko et al., 2005). Recent data sug-
gest that restricting centriole duplication to once per cell cycle is 
regulated by the F-box protein Slimb, which mediates proteolytic 
degradation  of  SAK  in  Drosophila  melanogaster  (Cunha- 
Ferreira et al., 2009; Rogers et al., 2009). In human cells, an auto-
regulatory feedback loop places Plk4 stability under direct control 
of its own activity and may form an important mechanism to limit 
normal centriole duplication to once per cell cycle (Holland et al., 
2010). Although Plk4 function is crucial for the regulation of cen-
triole formation, the underlying mechanisms remain scarce.
Results and discussion
To identify proteins that bind to Plk4, we prepared centrosome-
enriched fractions from KE37 cells by sucrose gradients fol-
lowed by biochemical pull-down assays with extracts derived 
from KI-extracted centrioles and recombinant double-tagged 
B
oth gain and loss of function studies have identified 
the Polo-like kinase Plk4/Sak as a crucial regulator 
of centriole biogenesis, but the mechanisms gov-
erning  centrosome  duplication  are  incompletely  under-
stood. In this study, we show that the pericentriolar material 
protein, Cep152, interacts with the distinctive cryptic Polo-
box of Plk4 via its N-terminal domain and is required   
for Plk4-induced centriole overduplication. Reduction of   
endogenous Cep152 levels results in a failure in centriole 
duplication, loss of centrioles, and formation of mono-
polar mitotic spindles. Interfering with Cep152 function pre-
vents recruitment of Plk4 to the centrosome and promotes 
loss of CPAP, a protein required for the control of centriole 
length in Plk4-regulated centriole biogenesis. Our results 
suggest that Cep152 recruits Plk4 and CPAP to the centro-
some to ensure a faithful centrosome duplication process.
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endogenous Cep152 in total cell extracts but recognizes over-
expressed Cep152 (Fig. S1 B) and in centrosome-enriched frac-
tions (Fig. S1 C). To analyze the interaction in vivo, we generated 
rabbit polyclonal and mouse monoclonal Plk4 antibodies that 
detect endogenous Plk4 (Fig. S1 D) and asked whether complexes 
between Plk4 and Cep152 could be detected in vivo. As seen   
in Fig. 1 B, endogenous Plk4 was present in Cep152 immuno-
precipitates. In addition, interactions between ectopically pro-
duced Myc-Plk4 and GFP-Cep152 that were coexpressed in 
293T cells could also be detected in vivo (Fig. 1 C). These   
results demonstrate that Plk4 and Cep152 stably associate,   
confirming our initial findings based on mass spectrometry.   
In contrast to other Polo-like kinase family members, the Polo-
box (PB) domain of Plk4 exhibits only a single PB, and the 
structural basis for its interaction with its binding partners is not 
fully understood (Leung et al., 2002). In addition, Plk4 contains 
Plk4 (N-terminal zz tag and C-terminal His tag) as bait. Mass 
spectrometrical analysis of eluted binding partners identified 
Cep152, a so far poorly characterized protein. Cep152 is the 
human  orthologue  (Blachon  et  al.,  2008)  of  the  Drosophila  
Asterless protein, a centriolar component required for centriole 
duplication  (Varmark  et  al.,  2007),  and  has  been  previously 
identified in a proteomic screen for centrosomal proteins in   
human cells (Andersen et al., 2003). To verify binding between 
Plk4 and Cep152, we first performed pull-down assays. Fig. 1 A 
shows an in vitro interaction between maltose-binding protein 
(MBP)–Plk4 and in vitro–translated [
35S]Cep152. These results 
suggest that the binding of Plk4 to Cep152 is direct. To further 
characterize  the  interaction  between  both  proteins,  we  have 
generated rabbit polyclonal antibodies against Cep152. Ab1140 
was selected for Western blotting (Fig. S1 A), and Ab26 was se-
lected for immunofluorescence (Fig. S3 D). Ab26 did not detect 
Figure 1.  Cep152 interacts with Plk4 in vitro and in vivo. (A) To analyze in vitro binding between Cep152 and Plk4, either MBP tag alone or MBP-tagged 
recombinant Plk4 immobilized on amylose beads was used in a binding assay with in vitro–translated [
35S]Cep152. Binding of [
35S]Cep152 to Plk4 was 
detected by autoradiography. Equal pull-down of MBP and MBP-Plk4 was shown by Coomassie staining. PD, pull-down. (B) Endogenous Cep152 was 
immunoprecipitated from U2OS cell extracts using Cep152 (Ab1140). Coprecipitated endogenous Plk4 was detected with a mouse anti-Plk4 antibody 
by Western blotting. Immunoprecipitation control, random rabbit IgGs. (C) Coimmunoprecipitation of Myc-Plk4 and GFP-Cep152 after coexpression in 
293T cells. Reciprocal immunoprecipitation Western blots were performed with anti-Myc and anti-GFP antibodies. Coprecipitated proteins were detected 
by Western blotting against the corresponding tag. (D, left) Different Flag-Plk4 fragments were coexpressed with GFP-Cep152 in 293T cells. Anti-Flag   
immunoprecipitates were analyzed in immunoblots for coprecipitated GFP-Cep152 using GFP antibodies. (right) Scheme of expressed Plk4 fragments.733 Cep152 recruits Plk4 to the centrosome • Cizmecioglu et al.
These data implicate that an interaction between these pro-
teins might be essential for centrosomal recruitment of Plk4.
To address whether Cep152 is required for Plk4-induced 
centrosome overduplication, we generated an HA-Plk4–over-
expressing HeLa cell line under the control of the tetracycline-
inducible promoter. Plk4 was induced through addition of 
doxycycline, and this resulted in a multiplication of -tubulin– 
positive dots (Fig. 4 A). Simultaneous down-regulation of 
Cep152 by siRNAs clearly interfered with Plk4-induced centro-
some reduplication by abrogating the reduplication phenotype 
(Fig. 4 A). The ability of Plk4 to induce the formation of multiple   
centrioles is regulated during the cell cycle. Cells that are synchro-
nized and held at the G1/S transition respond to Plk4 induction 
by the formation of flower-like centriolar structures (Fig. S3 C;   
Kleylein-Sohn et al., 2007). Down-regulation of Cep152 levels   
by siRNA leads to a reduction of flowers, as shown by cen-
trin or CP110 stainings. This reveals that the formation of   
Plk4-induced flower-like structures is dependent on Cep152 
(Fig. S3 C). Next, we asked whether the centrosomal localiza-
tion of Plk4 may be dependent on Cep152 and vice versa. Using 
Plk4-specific antibodies, we found that Plk4 was still detectable 
at the centrosome during the gradual knockdown of Cep152 
(Fig. S3 D). These data suggest that the maintenance of Plk4 
at the centrosome is not dependent on functional Cep152. Plk4 
siRNA expression shows that centrosomal binding of Cep152 
was also independent of Plk4 (Fig. S3 D). To find out whether 
the recruitment of newly synthesized Plk4 to the centrosome 
a cryptic PB that is required for its localization to the centrosome 
(Habedanck et al., 2005). To study the interaction in more detail, 
we mapped the binding sites between Plk4 and Cep152. We found 
that a fragment comprising the cryptic PB of Plk4 (aa 581–879) 
is required for binding to Cep152, whereas an interaction with 
the PB itself could not be detected (Fig. 1 D). These results indicate 
that the interaction mechanism of Plk4 with its binding partners 
is distinct from Plk1, which requires both PBs for phospho- 
dependent substrate targeting (Elia et al., 2003b).
To analyze the centrosomal localization of Cep152, we 
performed colocalization experiments with centrin-2, a centri-
olar marker, and found that the major fraction of Cep152 local-
ized around the centriole, and only a minor part colocalized 
with centrioles (Fig. 2 A). Immunoelectron microscopy was 
used to obtain more definitive insights into the localization of 
Cep152. We observed that endogenous Cep152 localizes to the 
PCM cloud embedding the outer wall at the proximal ends of 
the centriole but that it was not found in the centriolar lumen 
(Fig. 2 B). Moreover, endogenous Cep152 partially colocalized 
with Plk4. We detected a symmetrical localization of Plk4 to 
centrioles, whereas Cep152 staining was more asymmetrical, 
exhibiting a stronger signal around one of the two centrioles 
(Fig. 2 C). Upon analysis of Cep152 in an interphase stage and 
during different stages of mitosis, we found that Cep152 was 
always localized to centrosomes (Fig. S2 A). Analysis of the ex-
pression pattern of Cep152 in U2OS cells reveals that Cep152 
protein levels are low in mitosis but gradually increase during 
late G1 until S/G2 (Fig. S2, B and C). Despite the lower expres-
sion of Cep152 during mitosis, the protein still localizes to the 
mitotic centrosome but to a lesser extent (Fig. S2 D).
To determine whether centriole reduplication in S phase–
arrested U2OS cells required the presence of Cep152, the 
protein was down-regulated by specific siRNAs (O1 and O2).   
As Cdk2 activity is required for centriole duplication (Hinchcliffe 
et al., 1999; Lacey et al., 1999; Matsumoto et al., 1999; Meraldi 
et al., 1999), Cdk2 siRNAs were used as a positive control.   
As summarized in Fig. 3 A, ablation of Cep152 function interfered 
with centriole reduplication. Next, we analyzed whether down-
regulation of Cep152 also plays a role in the unperturbed cen-
trosome cycle in U2OS cells. Because a reduction in centriole 
numbers was expected to produce the most striking phenotypes 
during cell division, we focused our analysis on mitotic cells 
in the siRNA-treated populations. 72 h after Cep152 depletion, 
>20–25% of the mitotic cells displayed monopolar spindles in 
comparison with 4% in control cells. (Fig. 3 B). Cep152 con-
tains eight predicted coiled-coil regions (Fig. S3 A). Mapping of 
the region in Cep152 that binds to Plk4 reveals that a fragment 
comprising the first three coiled-coil regions (aa 1–512) is suf-
ficient for binding to Plk4 (Fig. S3 A). Interestingly, although 
Cep152  binds  to  Plk4  via  its  N-terminal  region  (fragment 
Cep152 1–512), the region that confers centrosomal localization 
of Cep152 is distinct and located at its C terminus (Fig. S3 B). We 
also found that overexpression of the Cep152 N-terminal frag-
ment exhibits a dominant-negative effect and therefore interferes 
with centriole duplication (Fig. 3 C). Interestingly, we observed 
that expression of the dominant-negative Cep152 1–512 frag-
ment prevents Plk4 localization at the centrosome (Fig. 3 D).   
Figure  2.  Cep152  localizes  to  the  PCM.  (A)  Immunofluorescence   
images showing that a minor fraction of endogenous Cep152 (red) 
colocalizes with the centriolar marker centrin-2 (green) in U2OS cells. (top) 
Cell with four centrioles. (bottom) Cell with two centrioles. (B) Immuno-
gold EM of U2OS cells shows that Cep152 localizes to the PCM cloud sur-
rounding the outer wall at the proximal ends of the centriole. Cep152 
localization on transversial sections (a) and longitudinal sections of one 
centriole (b and b’) are shown. (C) Costaining of U2OS cells with anti-
bodies against Cep152 (red) and Plk4 (green). Bars: (A and C) 2 µm; 
(B) 0.5 µm.JCB • VOLUME 191 • NUMBER 4 • 2010   734
Figure 3.  Cep152 is required for centriole duplication. (A) U2OS cells were transfected with siRNAs against Cdk2 (positive control), Cep152 (O1 and O2),   
GL2 (negative control), and arrested in S phase by aphidicolin treatment. 70 h later, cells with more than four centrioles were counted. Red, Cep152; 
green, centrin-2; blue, DNA. (B) U2OS cells were transfected with either GL2 or Cep152 siRNAs (O1 or O2). Spindle poles were depicted with centrin 
staining (green, centrin-2) and mitotic spindles with -tubulin antibodies (red) or DNA (blue). 72 h after transfection, cells with monopolar or bipolar mi-
totic spindles were counted. (C) U2OS cells were transfected with either GFP or GFP-Cep152 1–512 (green). Centrioles were visualized with centrin-2 
staining (red). 48 h and 72 h after transfection, cells with less than two centrioles were counted. (left) Representative pictures of the observed phenotypes.   
(D) Cep152 full length (FL), Cep152 fragments (1–512 and 508–end), or GFP were overexpressed in U2OS cells. 48 h after transfection, cells with or without 
centriolar Plk4 staining (blue) were counted. GT335 (red; Bobinnec et al., 1998), an antibody to modified tubulin, was used as a marker for centrosomes. Insets 
show enlargements of centrosomes as merged image and individual channels. Error bars show the SDs of at least three independent experiments. Bars, 5 µm.735 Cep152 recruits Plk4 to the centrosome • Cizmecioglu et al.
Figure 4.  Cep152 recruits Plk4 to the centrosome. (A) Centriole overduplication in HeLa Tet-on cells was forced by induction of Plk4 expression through 
addition of doxycycline. Simultaneously, cells were transfected with either GL2 or one of two different Cep152 siRNAs (O1 or O2). Centrosomes were 
stained with -tubulin (green) antibodies or Cep152 (red). 72 h after transfection, cells with less than two centrosomes were counted. (B) Hela Tet-on cells 
were transfected with GL2 or Cep152 siRNAs (O1 and O2) treated with aphidicolin for 24 h. Plk4 expression was induced in the last 20 h of aphidicolin 
treatment. Cells were scored for centrosomal HA-Plk4 signal. Induced HA-Plk4 signal (green) locates to the centrosome (red, -tubulin). Blue, DNA. (right) 
Insets display enlargements of the selected regions in the indicated channels (arrowheads). The last set of insets includes a triple merge. Corresponding 
immunoblots from siRNA-treated and induced cells were analyzed for Plk4 levels using antibodies against HA and Plk4 in comparison with uninduced, 
control siRNA-treated samples. (A and B) Error bars indicate SDs (n = 3). (C) Dynamics of Plk4 at centrosomes in response to Cep152 RNAi. FRAP was 
performed on U2OS cells treated with either GL2 or Cep152 siRNAs (O2) for 60 h followed by GFP-Plk4 transfections for 14 h. GFP-Plk4–positive, unsplit 
centrosomes in the same plane of focus were selected for photobleaching and subsequent imaging. 80 × 80–pixel squares surrounding the centrosome 
were bleached (bleach time 2.5 s), and the recovery of GFP fluorescence on centrosomes was imaged over time. (left) Arrows mark photobleached regions 
on the centrosome. (right) Relative expression levels of GFP-Plk4 in GL2- and O2-transfected cells were determined. (bottom) Mean fluorescence recovery 
profiles of GFP-Plk4 on the centrosome were depicted in GL2- and O2-treated cells (n = 12). Mean t1/2 of experiments is shown ± SD. Student’s t test was 
performed with GL2 or Cep152 siRNA-treated cells for recovery of GFP-Plk4 on the centrosome with P < 0.0001. Bars: (A) 5 µm; (B) 20 µm; (C) 3 µm.JCB • VOLUME 191 • NUMBER 4 • 2010   736
In summary, our data identify the centriolar protein Cep152, 
a protein involved in centriole duplication, as a novel Plk4-binding 
protein and the first binding partner to interact with the cryptic PB 
of Plk4. Cep152 partially colocalizes with Plk4 around the centri-
oles and is required for Plk4-induced centriole overduplication. 
Therefore, Cep152 is a critical component of the Plk4-dependent 
centriole assembly pathway, as Plk4 cannot trigger centriole dupli-
cation in the absence of Cep152 (Fig. 4 A). Cep152 localization to 
the centrosome is also crucial for recruitment of CPAP to the centro-
some. It is conceivable that the interaction between Plk4 and 
Cep152 might facilitate the recruitment of other components, such 
as CPAP, to trigger centriole duplication. Interestingly, a recent 
study by Chang et al. (2010) suggests that CPAP might be a physi-
ological substrate of Plk4. Together, Cep152 seems to regulate the 
recruitment of Plk4 to the centrosome and the maintenance of 
CPAP at this structure.
The 3D structure of Plk4 suggests a binding mechanism 
different from Plk1 (Leung et al., 2002). The Plk1 PB binds to 
target proteins after their phosphorylation (Elia et al., 2003a,b). 
However, the interaction of Plk4 and Cep152 occurs through its 
single cryptic PB in the absence of phosphorylation, although 
we currently cannot exclude that a phosphorylation event might 
regulate this interaction. In conclusion, our findings provide 
important mechanistic insights into the process of procentriole 
assembly, implicating Cep152 as a critical component in Plk4-
induced procentriole formation.
Materials and methods
Culturing of cells, generation of stable cell lines, transfections, and  
cell synchronization
HeLa cells, HeLa Tet-on cells, and U2OS cells were grown in DME (Sigma-
Aldrich) containing 1 g/liter glucose, 10% fetal calf serum, and 2 mM gluta-
mine. 293T and KE37 cells were grown in DME containing 4.5 g/liter 
glucose, 10% fetal calf serum, 2 mM glutamine, 100 U/ml penicillin, and 
100 µg/ml streptomycin. Inducible HeLa Tet-on cells stably expressing   
HA-Plk4 were generated by cotransfection of cells that carry Tet-on trans-
activators (Takara Bio Inc.) with pTREtight-HA-Plk4 and pPuro vector (Takara 
Bio Inc.) containing a marker for puromycin resistance. For induction of 
HA-Plk4 expression, media were supplemented with 2 µg/ml doxycycline. 
Cells were analyzed 20–48 h after induction. 293T cells were transfected 
with Ca
2+ phosphate according to standard protocols. HeLa, HeLa Tet-on, 
and U2OS cells were transfected with Lipofectamine 2000 (Invitrogen) for 
siRNA transfections or with Polyfect (QIAGEN) for plasmid DNA transfec-
tions. For overduplication assays, U2OS cells were arrested in S phase 
by supplementation of media with 1.9 µg/ml aphidicolin. Cells were ana-
lyzed 70 h after aphidicolin addition. U2OS cells were arrested in mitosis 
by supplementation of media with 100 ng/ml nocodazole for 17 h. For 
dT-Block, U2OS cells were treated with 4 mM thymidine for 19 h, released 
for 12 h, and again blocked for 15 h.
For  observing  Plk4-dependent  flower-like  procentriole  formation, 
HeLa Tet-on HA-Plk4 wild-type cells were treated with siRNAs for 70 h and 
supplemented with 2 µg/ml aphidicolin for 24 h. Plk4 expression was in-
duced for the last 20 h of aphidicolin treatment.
Antibodies and Western blotting
Rabbit anti-Plk4 and mouse anti-Plk4 antibodies were raised against a syn-
thetic peptide spanning residues 564–579 of Plk4. Rabbit anti-Cep152 
(Ab26) antibody was raised against a synthetic peptide spanning residues 
26–39 of Cep152. A second rabbit anti-Cep152 (Ab1140) antibody was 
raised against the Cep152 fragment spanning aa 1,140–1,308 that was 
expressed as a GST fusion protein in Escherichia coli and used for immuni-
zation. All antibodies were affinity purified using corresponding peptides 
or protein fragments immobilized on CNBr-activated Sepharose.
Rabbit anti-GFP antibody (NB600-303) was purchased from Novus 
Biologicals. Mouse anti–c-Myc (9E10), mouse anti-Plk1 (36–298), and mouse 
was impaired by the absence of Cep152, we again made use of 
the Plk4-inducible HeLa cell line (Fig. 4 B) and found that the 
recruitment of newly synthesized Plk4 to the centrosome was 
severely impaired when Cep152 was absent (Fig. 4 B), although   
overall levels of induced Plk4 remained unchanged (Fig. 4 B). 
To address the involvement of Cep152 in the dynamics of Plk4 
recruitment  to  the  centrosome,  FRAP  was  performed  with 
U2OS cells transiently expressing GFP-Plk4 for a short time. 
Cells were treated with GL2 or Cep152 siRNAs 60 h before 
the plasmid DNA transfections. As shown in Fig. 4 C, for both 
GL2- and Cep152-siRNA treated cells, Plk4 recovery reached 
a plateau after 70 s with a total intensity of 20% of the pre-
bleaching value. These data indicate the presence of rapidly 
exchanging (20%) and static pools (80%) of Plk4 on the 
centrosome. Interestingly, the rate of fluorescence recovery on 
the centrosome was partially impaired in cells down-regulated 
for Cep152. The mean t1/2 of Cep152 siRNA-treated cells was 
calculated to be 17.4 s, whereas the mean t1/2 for GL2-transfected 
cells was 11.2 s. This may imply that Plk4 exchanges between 
centrosomal and noncentrosomal pools with slower kinetics in 
the absence (or partial loss) of Cep152. Thus, Cep152 might 
function as a protein that recruits Plk4 to the centrosome, thus 
facilitating centrosome duplication.
The canonical pathway of centriole biogenesis has been 
previously described in exquisite detail at the ultrastructural level 
(Strnad and Gönczy, 2008). Several human centrosomal proteins 
indispensable for Plk4-dependent procentriole formation have 
been identified and include hsSas6 (Leidel et al., 2005), CPAP 
(Kohlmaier et al., 2009), (Tang et al., 2009), CP110 (Kleylein-
Sohn et al., 2007), and Cep135 (Ohta et al., 2002). To identify the 
role of Cep152 in this pathway, Cep152 was down-regulated by 
siRNA, and the centrosomal localization of these proteins was 
analyzed. We find that the localization of hsSas6, CP110, or 
Cep135 is not impaired by Cep152 siRNA treatment (Fig. 5 A). 
However, we cannot rule out that hsSas6, CP110, or Cep135 stably 
associated with centrioles before Cep152 depletion, similar to 
our observation with Plk4 localization. Interestingly, we observed 
that the SAS-4–related protein CPAP, which is required for centro-
some duplication and controls centriole length (Kohlmaier et al., 
2009; Schmidt et al., 2009; Tang et al., 2009), did not localize to 
centrioles upon Cep152 down-regulation (Fig. 5 A). Therefore, 
the localization of Cep152 at the centrosome is crucial for centro-
somal recruitment or maintenance of CPAP. To further confirm 
the link between Cep152 and CPAP, we analyzed the localization 
of these proteins within the flower-like structure upon over-
expression of Plk4 in colocalizations with the centriolar marker 
centrin-2 and Plk4 itself. Intriguingly, Cep152 exhibited a similar 
localization  that  was  described  for  CPAP,  namely  a  staining 
around parental centrioles and in between the nascent procentri-
oles (Fig. 5 B). Next, we asked whether Cep152 could interact 
with CPAP and found complexes between GFP-Cep152 and 
Flag-CPAP after coexpression in 293T cells in vivo (Fig. 5 C). 
Mapping of the region in Cep152 that binds to CPAP led to the 
finding that residues 513–1,074 of Cep152 are necessary for the 
interaction with CPAP (Fig. 5 D). Thus, Cep152 seems to form a 
scaffold with distinct regions for Plk4 and CPAP interactions and 
for centrosomal localization.737 Cep152 recruits Plk4 to the centrosome • Cizmecioglu et al.
Figure 5.  CPAP localization at the centrosome is dependent on Cep152. (A) U2OS cells were transfected with either GL2 or Cep152 siRNAs. Colocaliza-
tions of CPAP, hSas6, Cep135, and CP110 (red) together with -tubulin (green) were determined by immunofluorescence. Insets show enlargements of the 
merged image and individual channels. (right) Protein levels of the indicated proteins were determined by Western blotting. The graph shows a quantifica-
tion of the percentage of cells with centrosomal CPAP localization. Error bars indicate SDs (n = 3). (B, left) Cep152 and CPAP costainings (red) within the 
flower-like centrin-2 structures (green) were depicted. (B, right) Cep152 and CPAP colocalizations (red) were performed together with HA-Plk4 (green) using 
anti-HA antibodies. (C) Flag-CPAP and GFP or GFP-Cep152 constructs were coexpressed in 293T cells. GFP and GFP-Cep152 were immunoprecipitated 
48 h after expression. Coimmunoprecipitated Flag-CPAP was detected by Western blotting against the Flag tag. (D) Different GFP-Cep152 fragments (Fig. S3 A) 
were coexpressed with Flag-CPAP in 293T cells. Anti-GFP immunoprecipitates were analyzed by Western blotting for coprecipitated Flag-CPAP with anti-
Flag antibodies. Bars: (A) 5 µm; (B, left) 1 µm; (B, right) 0.5 µm.JCB • VOLUME 191 • NUMBER 4 • 2010   738
After centrifugation for 10 min at 13,000 rpm, 2 µg anti-Flag, anti-Myc, or 
anti-GFP antibody was added to the supernatant. Proteins were immuno-
precipitated for 2 h at 4°C and collected by addition of 10 µl protein G–
Sepharose. After extensive washing, the beads were boiled in 2× SDS 
buffer  and  analyzed  by  SDS-PAGE  and  Western  blotting.  As  input,   
1% of each lysate was loaded. Endogenous Cep152 protein was immuno-
precipitated with Cep152 (fragment) antibody. As control, random IgGs 
(Santa Cruz Biotechnology, Inc.) were used.
Antibodies and indirect immunofluorescence
Cells grown on coverslips were fixed with ice-cold methanol for 10 min at 
20°C. They were washed with PBS and blocked with 2% BSA/PBS for   
30 min. Cells were incubated with primary antibodies for 1 h and with sec-
ondary antibodies for 30 min. DNA was stained with Hoechst. Between each 
step, cells were washed three times with 2% BSA/PBS. All incubations took 
place at room temperature. Images were taken with a spinning-disc con-
focal (Ultra-View; PerkinElmer) objective on an inverted microscope (Ti; Nikon) 
connected to an electron multiplying charge-coupled device camera (Hama-
matsu Photonics). Deconvolution was applied for visualizing the flower-like 
procentriole formation (Huygens Essentials) with a 100× NA 1.0 oil objective. 
Z stacks were taken at 150-nm intervals, and maximum intensity projections 
were displayed. Images were later cropped in Photoshop (Adobe). Mouse 
anti–-tubulin (GTU-88) was purchased from Sigma-Aldrich, and rabbit anti– 
-tubulin (ab18251) was obtained from Abcam. Rabbit anti–centrin-2 (N-17) 
antibodies were obtained from Santa Cruz Biotechnology, Inc., and mouse 
anti–centrin-2 was obtained from J. Salisbury (Mayo Clinic, Rochester, MN). 
Mouse anti-GT335 was provided by C. Janke (Institut Curie, Paris, France), 
rabbit anti-hSAS6 and rabbit anti-CPAP were obtained from P. Gönczy, rabbit 
anti-Cep135 was obtained from R. Kuriyama (University of Minnesota, Min-
neapolis, MN), and rabbit anti-CP110 was obtained from B. Dynlacht (New 
York University, New York, NY). Alexa Fluor 488 and 594 anti–mouse, Alexa 
Fluor 488, 594, and 405 anti–rabbit, and Alexa Fluor 488 anti–rat were 
purchased from Invitrogen. Each independent counting of cells in this study in-
cludes ≥150 cells. Evaluation of the monopolar spindle phenotype was based 
on counting 50 cells per experiment.
Immunogold EM
U2OS cells were grown on coverslips, fixed with 2% formaldehyde, and 
permeabilized  with  0.05%  saponin  in  PBS.  Cells  were  incubated  with 
Cep152 (Ab26) antibody and rabbit anti-IgG Nanogold antibody for 3 h 
each. Cells were further fixed with 2.5% glutaraldehyde in 50 µM cacodyl-
ate buffer, and Nanogold was silver enhanced with HQ silver (Nanoprobes). 
Cells were dehydrated and embedded in epoxy resin.
FRAP analysis
For FRAP analysis, cells were cultured on glass-bottom dishes (Ibidi Integral 
Biodiagnostics) in a top environmental chamber (Tokai Hit Stage; Spectra Ser-
vices) and maintained at 37°C. FRAP was performed on a spinning-disc con-
focal unit (PerkinElmer) fitted on an inverted microscope (TE2000; Nikon) 
using a 100× NA 1.0 oil objective. A square region of interest (ROI) of 80 × 
80 pixels centered on unsplit centrosomes was bleached with 40 iterations 
and 100% laser power (488-nm argon laser). Two images were taken before 
bleaching with a 2-s interval. An image was taken every 1.5 s (488-nm argon 
laser at 4% power) after bleaching for the six initial recordings and then every 
3 s over a 100–120-s period. For each time point, images of four z stacks of 
0.5 µm optical section spacing were collected; the highest intensity recording 
of these four images was regarded as the in-focus intensity of the ROI. Centro-
somes with excessive z-axis movements that get out of the focal range by the 
end of the recording time were excluded from the analysis. Fluorescence inten-
sity of the photobleached ROI was determined using Volocity FRAP image ac-
quisition software. For processing and correction of time-lapse data, a standard 
algorithm (Khodjakov and Rieder, 1999) was used as follows: Ic = scaling fac-
tor × ([Ir  Ib]/[If  Ib]), where Ic is the corrected image, Ir is the noncorrected 
raw object fluorescent intensity, Ib is the background fluorescent intensity out-
side of the cells, If is the bright reference of the fluorescent intensity of a cluster 
of cells, and the scaling factor is the brightest pixel value in the bright reference 
image (after subtraction of the Ib). After this normalization, mean fluorescence 
intensities of the prebleaching images were set as 100%, and the subsequent 
relative recovery percentages were calculated for the remaining time points. 
Images were processed in Photoshop, and t1/2 values were determined using 
Volocity. The p-value for GFP-Plk4 recovery on the centrosome upon GL2 and 
O2 siRNA-treated samples was calculated using a two-tailed Student’s t test.
siRNAs
siRNAs used in this study were directed against the following sequences: 
firefly luciferase (GL2), 5-AACGTACGCGGAATACTTCGA-3; Plk4 O1, 
anti–cyclin E (H12) were purchased from Santa Cruz Biotechnology, Inc. 
Mouse  anti-FlagM2  (F3165)  and  mouse  anti–-tubulin  were  obtained   
from Sigma-Aldrich, mouse anti-actin (JLA20) was obtained from EMD,   
and mouse anti-HA was obtained from Babco. Peroxidase-conjugated   
donkey anti–rabbit and goat anti–mouse antibodies were purchased from 
Jackson ImmunoResearch Laboratories, Inc.
Recombinant protein expression
All recombinant proteins were expressed in BL21-Rosetta in the presence 
of 2% glucose and 1.5% ethanol. Protein expression was induced with 
0.5 mM isopropylthio--d-galactoside for 15 h at 18°C. Plk4 carrying a 
C-terminal His tag and an N-terminal zz tag (Jäkel and Görlich, 1998) 
was natively purified by single-step affinity chromatography using Ni-NTA   
Sepharose (QIAGEN) according to the instructions of the manufacturer, 
and MBP-Plk4 was natively purified via amylose beads (New England Bio-
labs, Inc.). In all cases, lysis buffer was 50 mM Tris, pH 7.5, 250 mM 
NaCl, 2 mM MgCl2, 5% glycerol, and 0.25% NP-40. All proteins were 
frozen in liquid nitrogen and stored at 80°C.
Molecular cloning
Plk4 wild type and K41R were PCR amplified from pX-HA-Plk4 (provided by 
D. Spengler, German Cancer Research Center, Heidelberg, Germany) and 
cloned into the PciI and BamHI sites of pQE80zz (provided by D. Görlich, 
Max Planck Institute, Göttingen, Germany), into the BamHI and HindIII sites 
of pMAL-c2 (New England Biolabs, Inc.), into the BamHI and XhoI sites of 
pCMV-3Tag-1 (Agilent Technologies), and into the BamHI and XhoI sites of 
pCMV-3Tag-2 (Agilent Technologies). All Plk4 fragments were amplified by 
PCR and cloned into the HindIII and XhoI sites of pCMV-3Tag-1. Cep152 
was amplified by PCR from pCR-XL-Topo-Cep152 (GenBank/EMBL/DDBJ 
accession no. NM_014985) and cloned into the KpnI and XhoI sites of 
pEGFP-C1 (Takara Bio Inc.) and into the EcoRV and XhoI sites of pET-30c 
(EMD). All Cep152 fragments were cloned either into the XhoI and KpnI 
sites or into the XhoI and SmaI sites of pEGFP-C1. CPAP was amplified 
from pEGFP-CPAP (provided by P. Gönczy, École Polytechnique Fédèrale 
de Lausanne, Lausanne, Switzerland) by PCR and cloned into the BamHI 
and SalI sites of pCMV-3Tag-2 vector.
Interaction experiments
Centrosomes were isolated from KE37 cells by discontinuous gradient   
ultracentrifugation as described previously (Moudjou and Bornens, 1998). 
In brief, cell pellet was washed with TBS and 0.1× TBS/8% sucrose. Cells 
were resuspended with 0.1× TBS/8% sucrose and mixed with 0.5% NP-40 
lysis buffer. The suspension was shaken slowly for 30 min at 4°C and spun at 
2,500 g for 10 min. Hepes buffer and DNase were added to the supernatant 
to final concentrations of 10 mM and 1 µg/ml, respectively. After incubation 
for 30 min at 4°C, the mixture was gently underlaid with 60% sucrose solu-
tion and spun at 10,000 g for 30 min. The obtained centrosomal suspen-
sion was loaded onto a discontinuous sucrose gradient (70, 50, and 40%   
sucrose solutions from the bottom) and spun at 120,000 g for 1 h. Frac-
tions were collected from the top, diluted with Pipes buffer (10 mM Pipes), 
and spun at 20,400 g for 15 min.
Purified centrioles from 4.5 × 10
9 KE37 cells were resuspended in 
2 ml of binding buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 
0.25% NP-40, 10 mM -glycerophosphate, and 10 mM NaF) containing 
2 M KI and incubated on ice for 45 min. After centrifugation for 10 min at 
13,000 rpm, the supernatant was dialyzed stepwise against binding buffer 
containing 1 M KI, binding buffer containing 0.5 M KI, and binding buffer 
without KI. Precipitated proteins were pelleted by centrifugation for 10 min at 
13,000 rpm. For in vitro pull-down assay, half of the supernatant was added 
to either immobilized zz tag or immobilized zz-Plk4 (100 µg of each protein 
was immobilized on 100 µl IgG Sepharose) in binding buffer. The reactions 
were incubated at 4°C for 3 h and washed three times with binding buffer 
and once with binding buffer + 50 mM NaCl. Bound proteins were eluted 
with binding buffer + 850 mM NaCl, TCA precipitated, and analyzed by 
SDS-PAGE followed by silver staining and mass spectrometry.
For in vitro pull-down assay with in vitro–translated Cep152, 10 µg MBP   
or MBP-Cep152 was immobilized on 10 µl amylose beads and incubated 
with 20 µl of an in vitro translation reaction (50 µl total volume; TNT-Coupled 
Reticulocyte Lysate system; Promega) in NP-40 buffer (40 mM Tris, pH 7.5, 
150 mM NaCl, 0.5% NP-40, 5 mM EDTA, 10 mM -glycerophosphate, and 
5 mM NaF). After incubation for 2 h at 4°C, beads were washed three 
times with NP-40 buffer and boiled in 2× SDS buffer. Eluted material was 
separated by SDS-PAGE and subjected to autoradiography. As input, 5% 
of the in vitro translation was loaded.
For coimmunoprecipitations, 293T cells were transfected with the 
corresponding constructs. Cells were lysed in NP-40 buffer for 30 min on ice. 739 Cep152 recruits Plk4 to the centrosome • Cizmecioglu et al.
by autoregulating its own stability. J. Cell Biol. 188:191–198. doi:10 
.1083/jcb.200911102
Jäkel, S., and D. Görlich. 1998. Importin beta, transportin, RanBP5 and RanBP7 
mediate nuclear import of ribosomal proteins in mammalian cells. EMBO 
J. 17:4491–4502. doi:10.1093/emboj/17.15.4491
Khodjakov, A., and C.L. Rieder. 1999. The sudden recruitment of -tubulin to 
the centrosome at the onset of mitosis and its dynamic exchange through-
out the cell cycle, do not require microtubules. J. Cell Biol. 146:585–596. 
doi:10.1083/jcb.146.3.585
Kleylein-Sohn, J., J. Westendorf, M. Le Clech, R. Habedanck, Y.D. Stierhof, and 
E.A. Nigg. 2007. Plk4-induced centriole biogenesis in human cells. Dev. 
Cell. 13:190–202. doi:10.1016/j.devcel.2007.07.002
Ko, M.A., C.O. Rosario, J.W. Hudson, S. Kulkarni, A. Pollett, J.W. Dennis, and 
C.J. Swallow. 2005. Plk4 haploinsufficiency causes mitotic infidelity and 
carcinogenesis. Nat. Genet. 37:883–888. doi:10.1038/ng1605
Kohlmaier,  G.,  J.  Loncarek,  X.  Meng,  B.F.  McEwen,  M.M.  Mogensen, A. 
Spektor, B.D. Dynlacht, A. Khodjakov, and P. Gönczy. 2009. Overly long 
centrioles and defective cell division upon excess of the SAS-4-related 
protein CPAP. Curr. Biol. 19:1012–1018. doi:10.1016/j.cub.2009.05.018
Lacey, K.R., P.K. Jackson, and T. Stearns. 1999. Cyclin-dependent kinase control 
of centrosome duplication. Proc. Natl. Acad. Sci. USA. 96:2817–2822. 
doi:10.1073/pnas.96.6.2817
Leidel, S., M. Delattre, L. Cerutti, K. Baumer, and P. Gönczy. 2005. SAS-6 de-
fines a protein family required for centrosome duplication in C. elegans 
and in human cells. Nat. Cell Biol. 7:115–125. doi:10.1038/ncb1220
Leung,  G.C.,  J.W.  Hudson, A.  Kozarova, A.  Davidson,  J.W.  Dennis,  and  F. 
Sicheri. 2002. The Sak polo-box comprises a structural domain sufficient 
for mitotic subcellular localization. Nat. Struct. Biol. 9:719–724. doi:10 
.1038/nsb848
Matsumoto, Y., K. Hayashi, and E. Nishida. 1999. Cyclin-dependent kinase 2 
(Cdk2) is required for centrosome duplication in mammalian cells. Curr. 
Biol. 9:429–432. doi:10.1016/S0960-9822(99)80191-2
Meraldi, P., J. Lukas, A.M. Fry, J. Bartek, and E.A. Nigg. 1999. Centrosome du-
plication in mammalian somatic cells requires E2F and Cdk2-cyclin A. 
Nat. Cell Biol. 1:88–93. doi:10.1038/10054
Moudjou, M., and M. Bornens. 1998. Method of centrosome isolation from cul-
tured animal cells. In Cell biology: A Laboratory Handbook. Second edi-
tion. J.E. Celis, editor. Academic Press, San Diego. 111–119.
Nigg, E.A. 2006. Origins and consequences of centrosome aberrations in human 
cancers. Int. J. Cancer. 119:2717–2723. doi:10.1002/ijc.22245
Nigg, E.A. 2007. Centrosome duplication: of rules and licenses. Trends Cell 
Biol. 17:215–221. doi:10.1016/j.tcb.2007.03.003
Ohta, T., R. Essner, J.H. Ryu, R.E. Palazzo, Y. Uetake, and R. Kuriyama. 2002. 
Characterization of Cep135, a novel coiled-coil centrosomal protein in-
volved in microtubule organization in mammalian cells. J. Cell Biol. 
156:87–99. doi:10.1083/jcb.200108088
Peel, N., N.R. Stevens, R. Basto, and J.W. Raff. 2007. Overexpressing centriole-
replication proteins in vivo induces centriole overduplication and de novo 
formation. Curr. Biol. 17:834–843. doi:10.1016/j.cub.2007.04.036
Rogers, G.C., N.M. Rusan, D.M. Roberts, M. Peifer, and S.L. Rogers. 2009. The 
SCF
Slimb ubiquitin ligase regulates Plk4/Sak levels to block centriole re-
duplication. J. Cell Biol. 184:225–239. doi:10.1083/jcb.200808049
Schmidt, T.I., J. Kleylein-Sohn, J. Westendorf, M. Le Clech, S.B. Lavoie, Y.D. 
Stierhof, and E.A. Nigg. 2009. Control of centriole length by CPAP and 
CP110. Curr. Biol. 19:1005–1011. doi:10.1016/j.cub.2009.05.016
Strnad, P., and P. Gönczy. 2008. Mechanisms of procentriole formation. Trends 
Cell Biol. 18:389–396. doi:10.1016/j.tcb.2008.06.004
Tang, C.J., R.H. Fu, K.S. Wu, W.B. Hsu, and T.K. Tang. 2009. CPAP is a cell- 
cycle  regulated  protein  that  controls  centriole  length.  Nat.  Cell  Biol. 
11:825–831. doi:10.1038/ncb1889
Varmark, H., S. Llamazares, E. Rebollo, B. Lange, J. Reina, H. Schwarz, and C. 
Gonzalez. 2007. Asterless is a centriolar protein required for centrosome 
function and embryo development in Drosophila. Curr. Biol. 17:1735–
1745. doi:10.1016/j.cub.2007.09.031
5-AACTATCTTGGAGCTTTATAA-3;  Plk4  O2,  5-CTGGTAGTACTAGTTCA-
CCTA-3;  Cdk2,  5-AAGATGGACGGAGCTTGTTAT-3;  Cep152  O1, 
5-CAGCTCTTTGAGGCTTATGAG-3; and Cep152 O2, 5-GCGGATCCAA-
CTGGAAATCTA-3. All siRNAs were purchased from Applied Biosystems. 
Cells transfected with Plk4 siRNA were analyzed 2 d after transfection. 
Cells transfected with Cdk2 or Cep152 siRNAs were analyzed 3 d   
after transfection.
Online supplemental material
Fig. S1 shows characterization of Cep152 and Plk4 antibodies. Fig. S2   
shows analysis of Cep152 localization to centrosomes. Fig. S3 shows 
that Cep152 has distinct sites for Plk4 binding and centriolar localiza-
tion. Online supplemental material is available at http://www.jcb.org/ 
cgi/content/full/jcb.201007107/DC1.
We thank B. Dynlacht, D. Görlich, J. Salisbury, P. Gönczy, C. Janke, and   
R. Kuriyama for reagents and U. Engel and C. Ackermann (Nikon Imaging 
Center, Heidelberg, Germany) for equipment and assistance.
This work was supported by the Deutsche José Carreras-Leukämiestiftung 
(grant DJCLS R07/21v to I. Hoffmann).
Submitted: 20 July 2010
Accepted: 11 October 2010
References
Andersen, J.S., C.J. Wilkinson, T. Mayor, P. Mortensen, E.A. Nigg, and M. Mann. 
2003. Proteomic characterization of the human centrosome by protein 
correlation profiling. Nature. 426:570–574. doi:10.1038/nature02166
Basto, R., K. Brunk, T. Vinadogrova, N. Peel, A. Franz, A. Khodjakov, and J.W. 
Raff. 2008. Centrosome amplification can initiate tumorigenesis in flies. 
Cell. 133:1032–1042. doi:10.1016/j.cell.2008.05.039
Bettencourt-Dias, M., and D.M. Glover. 2007. Centrosome biogenesis and func-
tion: centrosomics brings new understanding. Nat. Rev. Mol. Cell Biol. 
8:451–463. doi:10.1038/nrm2180
Bettencourt-Dias, M., A. Rodrigues-Martins, L. Carpenter, M. Riparbelli, L. 
Lehmann, M.K. Gatt, N. Carmo, F. Balloux, G. Callaini, and D.M. Glover. 
2005. SAK/PLK4 is required for centriole duplication and flagella devel-
opment. Curr. Biol. 15:2199–2207. doi:10.1016/j.cub.2005.11.042
Blachon,  S.,  J.  Gopalakrishnan, Y.  Omori,  A.  Polyanovsky,  A.  Church,  D. 
Nicastro, J. Malicki, and T. Avidor-Reiss. 2008. Drosophila asterless and 
vertebrate  Cep152  Are  orthologs  essential  for  centriole  duplication. 
Genetics. 180:2081–2094. doi:10.1534/genetics.108.095141
Bobinnec, Y.,  M.  Moudjou,  J.P.  Fouquet,  E.  Desbruyères,  B.  Eddé,  and  M. 
Bornens. 1998. Glutamylation of centriole and cytoplasmic tubulin in 
proliferating non-neuronal cells. Cell Motil. Cytoskeleton. 39:223–232. 
doi:10.1002/(SICI)1097-0169(1998)39:3<223::AID-CM5>3.0.CO;2-5
Chang, J., O. Cizmecioglu, I. Hoffmann, and K. Rhee. 2010. PLK2 phosphoryla-
tion is critical for CPAP function in procentriole formation during the cen-
trosome cycle. EMBO J. 29:2395–2406. doi:10.1038/emboj.2010.118
Cunha-Ferreira, I., A. Rodrigues-Martins, I. Bento, M. Riparbelli, W. Zhang, E. 
Laue, G. Callaini, D.M. Glover, and M. Bettencourt-Dias. 2009. The SCF/
Slimb ubiquitin ligase limits centrosome amplification through degrada-
tion of SAK/PLK4. Curr. Biol. 19:43–49. doi:10.1016/j.cub.2008.11.037
Elia, A.E., L.C. Cantley, and M.B. Yaffe. 2003a. Proteomic screen finds pSer/
pThr-binding  domain  localizing  Plk1  to  mitotic  substrates.  Science. 
299:1228–1231. doi:10.1126/science.1079079
Elia, A.E., P. Rellos, L.F. Haire, J.W. Chao, F.J. Ivins, K. Hoepker, D. Mohammad, 
L.C. Cantley, S.J. Smerdon, and M.B.  Yaffe. 2003b. The molecular basis for 
phosphodependent substrate targeting and regulation of Plks by the Polo-
box domain. Cell. 115:83–95. doi:10.1016/S0092-8674(03)00725-6
Ganem, N.J., S.A. Godinho, and D. Pellman. 2009. A mechanism linking   
extra  centrosomes  to  chromosomal  instability.  Nature.  460:278–282. 
doi:10.1038/nature08136
Habedanck, R., Y.D. Stierhof, C.J. Wilkinson, and E.A. Nigg. 2005. The Polo ki-
nase Plk4 functions in centriole duplication. Nat. Cell Biol. 7:1140–1146. 
doi:10.1038/ncb1320
Hinchcliffe, E.H., and G. Sluder. 2001. “It takes two to tango”: understanding 
how centrosome duplication is regulated throughout the cell cycle. Genes 
Dev. 15:1167–1181. doi:10.1101/gad.894001
Hinchcliffe,  E.H.,  C.  Li,  E.A.  Thompson,  J.L.  Maller,  and  G.  Sluder. 
1999.  Requirement  of  Cdk2-cyclin  E  activity  for  repeated  centro-
some  reproduction  in  Xenopus  egg  extracts.  Science.  283:851–854. 
doi:10.1126/science.283.5403.851
Holland, A.J.,  W.  Lan,  S.  Niessen,  H.  Hoover,  and  D.W.  Cleveland.  2010. 
Polo-like kinase 4 kinase activity limits centrosome overduplication 